XCE tirzepatide is a dual GIP and GLP-1 receptor agonist developed for research applications. Our pharmaceutical grade product meets the highest quality standards with 99.9% purity and comprehensive analytical documentation.
As a specialized peptide manufacturer, we offer XCE tirzepatide in various package sizes to meet different research requirements. The product undergoes strict quality control including HPLC, MS, and amino acid analysis to ensure batch-to-batch consistency.
XCE tirzepatide (LY3298176) has shown promising research potential in metabolic studies. Our production follows GMP guidelines with complete traceability from raw materials to finished product.
Key advantages of our XCE tirzepatide include: